Cite
Myocardial microvascular function assessed by CMR first-pass perfusion in patients treated with chemotherapy for gynecologic malignancies.
MLA
Yang, Meng-Xi, et al. “Myocardial Microvascular Function Assessed by CMR First-Pass Perfusion in Patients Treated with Chemotherapy for Gynecologic Malignancies.” European Radiology, vol. 32, no. 10, Oct. 2022, pp. 6850–58. EBSCOhost, https://doi.org/10.1007/s00330-022-08823-2.
APA
Yang, M.-X., Li, Q.-L., Wang, D.-Q., Ye, L., Li, K.-M., Lin, X.-J., Li, X.-S., Fu, C., Ma, X.-M., Guo, Y.-K., Yin, R.-T., & Yang, Z.-G. (2022). Myocardial microvascular function assessed by CMR first-pass perfusion in patients treated with chemotherapy for gynecologic malignancies. European Radiology, 32(10), 6850–6858. https://doi.org/10.1007/s00330-022-08823-2
Chicago
Yang, Meng-Xi, Qing-Li Li, Dan-Qing Wang, Lu Ye, Ke-Min Li, Xiao-Juan Lin, Xue-Sheng Li, et al. 2022. “Myocardial Microvascular Function Assessed by CMR First-Pass Perfusion in Patients Treated with Chemotherapy for Gynecologic Malignancies.” European Radiology 32 (10): 6850–58. doi:10.1007/s00330-022-08823-2.